A general consensus seems to have emerged after last week’s oral arguments in the case against the abortion pill that the Supreme Court is likely to rule that the anti-abortion physicians and their umbrella group, the Alliance for Hippocratic Medicine, lack sufficient legal grounds to challenge the FDA’s loosening of restrictions on mifepristone. While dismissal based on a lack of standing would be a welcome result, it is not a guarantee given the Court’s anti-abortion supermajority. Bu...